Ibex Technologies Stock Fundamentals
| IBT Stock | EUR 684.00 10.00 1.48% |
IBEX Technologies fundamentals help investors to digest information that contributes to IBEX Technologies' financial success or failures. It also enables traders to predict the movement of IBEX Stock. The fundamental analysis module provides a way to measure IBEX Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IBEX Technologies stock.
IBEX |
IBEX Technologies Company Profit Margin Analysis
IBEX Technologies' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current IBEX Technologies Profit Margin | 0.21 % |
Most of IBEX Technologies' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IBEX Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, IBEX Technologies has a Profit Margin of 0.2147%. This is 101.92% lower than that of the Healthcare sector and 100.93% lower than that of the Biotechnology industry. The profit margin for all Germany stocks is 116.91% lower than that of the firm.
IBEX Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IBEX Technologies's current stock value. Our valuation model uses many indicators to compare IBEX Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IBEX Technologies competition to find correlations between indicators driving IBEX Technologies's intrinsic value. More Info.IBEX Technologies is rated below average in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IBEX Technologies is roughly 1.58 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IBEX Technologies' earnings, one of the primary drivers of an investment's value.IBEX Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IBEX Technologies' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IBEX Technologies could also be used in its relative valuation, which is a method of valuing IBEX Technologies by comparing valuation metrics of similar companies.IBEX Technologies is currently under evaluation in profit margin category among its peers.
IBEX Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 4.1 M | |||
| Shares Outstanding | 24.78 M | |||
| Shares Owned By Insiders | 26.73 % | |||
| Price To Earning | 6.10 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 7.89 M | |||
| Gross Profit | 5.36 M | |||
| EBITDA | 2.83 M | |||
| Net Income | 1.67 M | |||
| Cash And Equivalents | 4.21 M | |||
| Cash Per Share | 0.17 X | |||
| Total Debt | 666.13 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 7.11 X | |||
| Book Value Per Share | 0.42 X | |||
| Cash Flow From Operations | 3.58 M | |||
| Earnings Per Share | 0.05 X | |||
| Beta | 0.0142 | |||
| Market Capitalization | 14.6 M | |||
| Total Asset | 12.97 M | |||
| Z Score | 12.6 | |||
| Net Asset | 12.97 M |
About IBEX Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IBEX Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IBEX Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IBEX Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada. IBEX TECHS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in IBEX Stock
IBEX Technologies financial ratios help investors to determine whether IBEX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IBEX with respect to the benefits of owning IBEX Technologies security.